|
DIABETES IN CONTROL
|
Kristina
Sandstedt, MS
|
|
 Kristina
Sandstedt,
MS,
Clinical
Exercise
Physiologist,
Diabetes
Educator
“The
Role
of
Exercise
in
the
Treatment
of
Arthritis”,
Why
this
information
is
important
for
Diabetes
Educators
|
|
|
|
Evan
D.
Rosen,
M.D.,
Ph.D
|
|
Dr.
Evan
Rosen
 Winning
the
Battle,
but
Losing
the
War
|
|
|
|
Shafer
Monthly Feature
|
|
 “ANTIOXIDANTS”
Antioxidants
have
received
a
lot
of
attention
in
recent
years,
in
relation
to
wellness
and
disease
prevention.
More
studies
are
needed
to
better
understand
how
antioxidants
may
affect
diabetes
management
and
treatment.
Click
Here
By Sherri Shafer,
R.D., CDE,
View
Sherri's Archives
|
|
|
|
NOMINATE YOUR
CHOICE
|
|
Best
Diabetes
Product
or
Service
of
the
New
Millennium
Medical
Professionals
CHOICE
AWARD
CLICK
HERE
|
|
|
Dr. Eric S. Freedland
|
|
 Dr.
Eric Freedland
continues his series
Why
Focusing On Intensive Glucose Control With Drugs Alone Is
Counterproductive with
Part
10
Manipulating
Macronutrient
Ratios
Eric S. Freedland, MD
|
|
|
|
PRINT
THE NEWSLETTER
|
|
Print this weeks Newsletter Here.
Adobe
format
22
pages
Download
Adobe format
click here.
|
| |
|
|
|
Dr.
Thomas Burke Ph.D
|
-
 Dr
Thomas Burke brings
us a wound care case study by Alan
Kochman, PT, MS and Diane
Pogmore, RN, CWOCN
|
|
|
|
SUBSCRIBE |
|
|
|
|
Item #5
ADA:
Post-Challenge Glucose Levels Correlated Directly to Cardiovascular
Outcomes
Treatment
of post-challenge glucose (PCG) levels may reduce cardiovascular
disease and mortality associated with type 2 diabetes.
Hyperglycemia has been shown in prior research to add significantly to
adverse outcomes associated with type 2 diabetes. Recent studies have
indicated that higher than normal PCG may be an independent factor
associated with morbidity and mortality.
The investigators undertook a review of published data to evaluate the
association of elevated PCG levels with cardiovascular outcomes and
all-cause mortality in type 2 diabetes and to establish the strength
of this association in comparison to fasting blood glucose (FPG)
levels.
They conducted a MEDLINE search of English-language articles published
from 1980-2001, supplemented by a search of bibliographies and
references supplied by content experts. They used specific criteria to
find articles addressing the association of PCG and cardiovascular
morbidity/mortality and/or all-cause mortality.
They found 4,242 pertinent references in the literature. They finally
accepted 14 studies for the review, 12 prospective and 2
cross-sectional.
Twelve of the studies (85 percent) documented a positive association
between elevated PCG and cardiovascular morbidity/mortality and/or
all-cause mortality in type 2 diabetes.
Seven studies provided direct comparison data on FPG and PCG levels.
Five studies (71 percent) indicate that PCG is a better predictor of
cardiovascular morbidity/mortality and/or all-cause mortality than FPG.
The other 2 studies indicated no association between either FPG or PCG
and morbidity or mortality.
"Fasting plasma glucose is an important screening tool in
diabetes," said investigator Myriam Bernal, research associate at
ZYNX Health in Los Angeles. "We also found that there is powerful
evidence in the wider medical literature to support the belief that
post challenge glucose, if it's higher, is directly correlated with
cardiovascular outcomes. It should be targeted by physicians."
The study was supported by a grant from Novartis
Pharmaceuticals.
Advertorial
Snoring
increases diabetes risk.
A recent study in the American
Journal of Epidemiology Vol. 155, No. 5 : 387-393 indicated
that snoring was an independent risk factor in the eventual
diagnosis of diabetes. In addition irregular sleep patterns have
been associated with hormonal imbalance, possibly affecting fasting
glucose values. If you have diabetes and live with a snorer, your
interrupted sleep patterns can affect your glucose as well.
Traditional
products often have side effects and are not highly successful in
reducing or eliminating snoring. The ingredients in GlucoFree
SnoreQuell are proven to decrease or eliminate snoring without
raising blood glucose levels. Learn
More here.
[an error occurred while processing this directive]
|
DIABETES NEWS FLASH
|
Dr.
Jennifer Larson
Feature
|
|
Dr
Jennifer Larson, MD,
University
of Nebraska Medical Center, gave
a very informative overview of Pancreas,
Islet, and Kidney Transplantation: Metabolic and Endocrine
Consequences, at the Endo2002 conference. We have an overview
of her presentation, click
here
|
|
|
|
TOP
DIABETES STORIES
|
|
New
Drug Restores Eyesight*
Click
Here
Diabetes
Management Market Predicted to Explode*
Click
Here
Night-Light
May Prevent Diabetic Eye Damage*
Click
Here
New
Test Predicts Which Type 2’s Will Become Type 1’s Within 5 Years*
Click
Here
|
|
|
|
FREE
WEBSITE!!!
|
|
Get
a
FREE
website
for
your
Diabetes
Organization.
Click
Here
To
Learn
More
|
|
NEW PRODUCT
|
|
 400
needles
that
pierce
the
skin
and
let
big
molecules
enter
the
bloodstream.
Drug
delivery
with
this
techniques
offers
several
advantages
over
pills
and
injections.
It
can
ensure
the
steady
release
of
medication
into
the
patient's
bloodstream
over
long
periods,
improving
the
efficacy
of a
dose.
It
can
prevent
the
rapid
breakdown
that
many
drugs
taken
orally
undergo
when
they
pass
through
the
digestive
system.
Click
here
for
more
information:
|
|
|
|
Dr Richard K. Bernstein
|
|
This
Months Corner:
 Dr.
Bernstein's
Feature:
Will
eating a low-fat
diet help you
live longer?
|
|
|
|
INSIDE
DIABETES
|
|
David
Kliff
 The
Pump Market - A
Market in
Turmoil
ADA
Highlights
David
Kliff, Publisher
The Diabetic Investor
|
|
|
|
In
2 Nutrition
|
|
Generate
Individualized meal plans for your patients!
See how your
patients can receive over 250 personalized recipes that are ideal
for individuals with diabetes, high cholesterol, heart disease and
weight management problems.
|
|
|
NEWS
FLASH
!!!
|
|
Over
One
million
US
adults
can't
afford
their
drugs
Click
Here
|
|
|
|
FREE
CME!
|
|
Free
CME
The
Hyperactive
Platelet
in
Type
2
Diabetes-
sponsored
by
Baylor
College
of
Medicine,
Houston,
Texas,
offers
2
hours
of
AMA
PRA
category
1
credit
To
access
this
free
on-line
activity,
visit
Click
Here
|
|
|
|
